- Home
- LOMA vs OMCL Comparison
LOMA vs OMCL Comparison
Compare LOMA & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOMA | OMCL |
|---|---|---|
| Founded | 1926 | 1992 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Computer Manufacturing |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2017 | 2001 |
Fundamental Metrics
Financial Performance| Metric | LOMA | OMCL |
|---|---|---|
| Price | $12.79 | $43.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $15.00 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 548.6K | 511.1K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.06 | ★ 0.43 |
| Revenue | $464,306,268.00 | ★ $1,177,740,000.00 |
| Revenue This Year | $22.92 | $8.61 |
| Revenue Next Year | $25.84 | $3.97 |
| P/E Ratio | $212.05 | ★ $103.10 |
| Revenue Growth | N/A | ★ 10.67 |
| 52 Week Low | $7.04 | $22.66 |
| 52 Week High | $14.17 | $47.69 |
Technical Indicators
Market Signals| Indicator | LOMA | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 66.02 | 74.57 |
| Support Level | $11.90 | $39.18 |
| Resistance Level | $13.14 | $45.36 |
| Average True Range (ATR) | 0.53 | 1.91 |
| MACD | -0.02 | 0.53 |
| Stochastic Oscillator | 82.74 | 85.53 |
Price Performance
Historical ComparisonAbout LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS
Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.